Company Performance Metrics
Biohabit develops medical technology and in vitro diagnostic solutions focused on cardiovascular disease. The company concentrates on non-invasive point-of-care testing to support earlier detection and monitoring of heart failure. Its proprietary NT-proCheck test measures NT-proBNP using oral fluid samples instead of blood, reducing the need for
traditional venous blood draws. Biohabit designs its diagnostic tools so they can be used at or near the point of care without complex laboratory infrastructure. Its work spans biotechnology and medical device engineering, applying molecular biology methods within practical test formats. Biohabit also engages in research and development to refine its diagnostic platform and explore broader applications in cardiovascular medicine.
